Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Which of the Top 5 Beat-and-Raise Rallies of November 9 Rests on the Strongest Numbers: Telos (NASDAQ:TLS), Lincoln Educational (NASDAQ:LINC), Ferguson (NYSE:FERG), CNH Industrial (NYSE:CNH) or Constellation Energy (NASDAQ:CEG)?

Lincoln Educational (NASDAQ:LINC) closed up 24.58% on November 9 after third-quarter revenue rose 12.6% to USD 159.2 million from USD 141.4 million. The driver is enrollment. Student starts rose 14.2% to 7,362 on a comparable basis, the average student population grew 10.9%, and the …

Vinay Lochav | 10 November 2026

Why Did the Top 5 Beat-but-Sold Stocks Fall About 3% to 25% After Hours: Digital Turbine (NASDAQ:APPS), Exodus Movement (NYSEAMERICAN:EXOD), Rocket Lab (NASDAQ:RKLB), PubMatic (NASDAQ:PUBM) and Zeta Global (NYSE:ZETA)?

Exodus Movement (NYSEAMERICAN:EXOD) fell about 11% in after-hours trading on November 9 after third-quarter results. Revenue rose 7% to USD 32.5 million, above the roughly USD 29.4 million expected, but the company swung to a net loss of USD 8.3 million fromNet Incomeof USD …

Vinay Lochav | 10 November 2026

Which of the Top 5 Guidance Cuts of November 9 Hurts the Most: Ionis Pharmaceuticals (NASDAQ:IONS), Hims & Hers Health (NYSE:HIMS), Motorcar Parts of America (NASDAQ:MPAA), Repay Holdings (NASDAQ:RPAY) or Dole (NYSE:DOLE)?

Hims & Hers Health (NYSE:HIMS) closed at USD 22.98 on November 9, down 11.77% in the regular session before its after-close report, then touched USD 20.63 in extended trading. The cause of the daytime fall was not confirmed, but the results deepened it. Third-quarter …

Vinay Lochav | 10 November 2026

Which of the Top 5 Software and Ad-Tech Reports of November 9 Shows the Healthiest Growth: Trade Desk (NASDAQ:TTD), Life360 (NASDAQ:LIF), monday.com (NASDAQ:MNDY), Qualys (NASDAQ:QLYS) or Rackspace Technology (NASDAQ:RXT)?

Life360 (NASDAQ:LIF) reported third-quarter revenue of USD 174.1 million on November 9, up 40% from USD 124.5 million and ahead of expectations, the fastest growth in this group. Subscription revenue rose 29% to USD 124.2 million, and advertising revenue jumped 250% to USD 25.4 …

Vinay Lochav | 10 November 2026

How Badly Did the Top 5 Revenue Misses of November 9 Fall Short: Bakkt (NYSE:BKKT), ImmunityBio (NASDAQ:IBRX), Hain Celestial (NASDAQ:HAIN), loanDepot (NYSE:LDI) and Groupon (NASDAQ:GRPN)?

ImmunityBio (NASDAQ:IBRX) fell about 20% on November 9 to around USD 6.89, from USD 8.64 the previous Friday, on more than twice its average volume. Third-quarter net product revenue from Anktiva rose 53% to USD 48.7 million, but total revenue of about USD 48.8 …

Vinay Lochav | 10 November 2026

Which of the Top 5 Fastest-Growing Quarters, With Revenue Up 71% to 127%, Has the Most Durable Growth: Sterling Infrastructure (NASDAQ:STRL), Onto Innovation (NYSE:ONTO), Sanmina (NASDAQ:SANM), QXO (NYSE:QXO) or Delcath Systems (NASDAQ:DCTH)?

Onto Innovation (NYSE:ONTO) reported record third-quarter revenue of USD 409.7 million after the close on November 9, up 87.8% from USD 218.2 million and above the roughly USD 391.8 million expected. Non-GAAP earnings were USD 2.44 per share against USD 0.92 a year earlier, …

Vinay Lochav | 10 November 2026

Which of the Top 5 Capital Return Stories Is Best Funded: Berkshire Hathaway (NYSE:BRK.B), NRG Energy (NYSE:NRG), Steel Dynamics (NASDAQ:STLD), Barrick (NYSE:B) or KKR (NYSE:KKR)?

NRG Energy (NYSE:NRG) jumped 10.32% on November 9 after agreeing to sell six gas plants with 4.9 gigawatts of capacity to LS Power for USD 4 billion in cash, about 8.0 times expected 2027 EBITDA. The proceeds fund a clear capital plan: USD 3 …

Vinay Lochav | 10 November 2026

Which of the Top 5 Biotech Catalysts of November 9 Is Most Valuable: Vir Biotechnology (NASDAQ:VIR), Immunovant (NASDAQ:IMVT), Edesa Biotech (NASDAQ:EDSA), Roivant Sciences (NASDAQ:ROIV) or Viridian Therapeutics (NASDAQ:VRDN)?

Immunovant (NASDAQ:IMVT) rallied 15.1% to USD 35.15 from USD 30.53 after a positive rheumatoid arthritis study of IMVT-1402, which blocks the FcRn antibody-recycling receptor. In the randomizedWithdrawalperiod, 92.5% of patients on the 600 mg dose kept an ACR20 response at week 28, against 75.6% …

Vinay Lochav | 10 November 2026

Why Did the Top 5 Biotech Losers of November 9 Fall 15.4% to About 76%: Zura Bio (NASDAQ:ZURA), Faeth Therapeutics (NASDAQ:FTH), Janux Therapeutics (NASDAQ:JANX), Acadia Pharmaceuticals (NASDAQ:ACAD) and Arrowhead Pharmaceuticals (NASDAQ:ARWR)?

Faeth Therapeutics (NASDAQ:FTH) closed 42.5% lower on November 9, one of the steepest declines in the US market on a day when the S&P 500 rose about 2.4%. The trigger was preliminary Phase 2 PIK-201 data for its PIKTOR and paclitaxel combination in advanced …

Vinay Lochav | 10 November 2026

What Do the Top 3 FDA Stories of November 9 Mean for NovoCure (NASDAQ:NVCR), Eli Lilly (NYSE:LLY) and Definium Therapeutics (NASDAQ:DFTX)?

The FDA on November 9 ordered new warnings on all GLP-1 drugs about non-arteritic anterior ischemic optic neuropathy, or NAION, a rare eye condition that can cause sudden vision loss, affecting products from Eli Lilly (NYSE:LLY) and Novo Nordisk. The agency's review of more …

Vinay Lochav | 10 November 2026
Support

Hi! How can we help you today?

Loading…